Haemonetics Corp (NYSE: HAE) has reported earnings for its fourth fiscal quarter (ending March 31) of $0.40 versus $0.58 for the same period a year ago — a decline of -31%. This result fell short […]
Diodes Inc (NASDAQ: DIOD) has reported earnings for its first fiscal quarter (ending March 31) of $0.30 versus $1.56 for the same period a year ago — a decline of -81%. This performance was $-0.50 […]
For its first fiscal quarter (ending March 31), Camtek Ltd (NASDAQ: CAMT) has reported a 41% increase in E.P.S. from $0.39 a year ago to $0.55 in the current quarter. However, this performance was $-0.11 […]
Blue Bird Corp (NASDAQ: BLBD) stock enjoyed a major increase of 24.5% on 5/9/24. The shares closed at $46.72. Moreover, this advance was accompanied by exceptionally high trading volume at 604% of normal. The stock […]
Block H&R Inc (NYSE: HRB) has reported E.P.S. of $4.87 for its third fiscal quarter (ending March 31) versus $4.22 for the same period a year ago — an increase of 15%. For the latest […]
American Vanguard Corp (NYSE: AVD) has reported E.P.S. of $0.06 for its first fiscal quarter (ending March 31) versus $0.07 for the same period a year ago — a decline of -14%. E.P.S. were $0.26 […]
AMN Healthcare Services Inc. (NYSE: AMN) has reported earnings for its first fiscal quarter (ending March 31) of $0.45 versus $2.03 for the same period a year ago — a decline of -78%. This performance […]
Xencor Inc (NASDAQ: XNCR) has reported a loss for its first fiscal quarter (ending March 31) of $-1.11 versus a loss $-1.02 for the same period a year ago. This result fell short of the […]
For its first fiscal quarter (ending March 31), Wave Life Sciences Ltd (NASDAQ: WVE) has reported E.P.S. of $-0.24 compared to $-0.27 a year ago. This performance was $0.04 better than the consensus estimate of […]
United States Cellular Corp (NYSE: USM) stock closed at $45.95 on 5/9/24 after a major increase of 27.7%. Moreover, exceptionally high trading volume at 906% of normal accompanied the advance. The stock has risen 26.5% […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research